Over nearly ten years of work in Brazil, Argentina, and Mexico, we developed a multi-parameter telemedicine platform for the remote monitoring of chronic and discharged patients, supporting continuity of care.

A multi-parameter medical device designed to monitor vital signs and body acceleration during flight and training. Our first project, carried out in collaboration with the Frecce Tricolori pilots in 2005.

Developed within a major public telemedicine tender in L’Aquila, the project focused on home-care patients and the optimization of pain therapy. It features an innovative stainless-steel transport case, customizable with a tablet and integrated medical devices.

A geographical, interactive, and web-based solution developed for the Vodafone Angel project by the Vodafone Foundation, in collaboration with the Ministry of the Interior, aimed at enhancing safety and combating violence against women.

A prevention project for middle and high school students who, not practicing competitive sports, are not subject to mandatory cardiac screening. Students are monitored during school physical activity — an idea conceived by our beloved and much-missed friend, Dr. Franco Pesciatini.

A telemedicine project launched in Ivrea for monitoring blood coagulation in patients receiving home-based drug treatments. Developed within the Piedmont Region’s C.Lab Health Program: “Innovative Systems and Solutions for Personalized Care.”

A project dedicated to ensuring educational continuity for pediatric patients, carried out in a prestigious Italian children’s hospital in collaboration with the Vodafone Italia Foundation and Un Sogno per il Gaslini ONLUS. This experience deeply touched us, as it allowed us to work in close contact with young patients. We warmly thank Dr. Mancini for her trust and collaboration.

CRYO2: automatically adjustment of oxygen delivery and personalization of O₂ delivery for patients with COPD through the continuous monitoring of vital O₂ physiological variables. Our innovative CRYO2 product will be offered to O2 source device sector as device and to health care service providers as telemedicine service.